A phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

J. M. Kirkwood, P. Lorigan, P. Hersey, A. Hauschild, C. Robert, D. F. McDermott, J. Gomez-Navarro, J. Q. Liang, C. A. Bulanhagui

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)9023-9023
Number of pages1
JournalJournal of Clinical Oncology
Volume26
Issue number15_suppl
DOIs
Publication statusPublished - 20 May 2008

Cite this